Claims
- 1. A compound selected from the group consisting of a compound of the formula ##STR353## wherein R is selected from the group consisting of ##STR354## R.sub.a is selected from the group consisting of ArO--CH.sub.2 --, ArS--CH.sub.2 -- and R.sub.e --NH--, Ar and R.sub.e are individually selected ##STR355## from the group consisting of phenyl and phenyl substituted with at least one member of the group consisting of halogen, alkyl and alkoxy and alkylthio of 1 to 4 carbon atoms, alkylsulfinyl and alkylsulfonyl of 1 to 4 carbon atoms, --NH.sub.2, nitro, --OH, aminoalkyl of 1 to 4 carbon atoms, --CN and --CF.sub.3, R.sub.f is alkyl of 1 to 4 carbon atoms, R.sub.d is selected from the group consisting of a) hydrogen, b) alkyl of 1 to 6 carbon atoms, c) alkenyl and alkynyl of 2 to 6 carbon atoms, d) cycloalkyl of 3 to 8 carbon atoms unsubstituted or substituted with a member of the group consisting of halogen, acyl of 1 to 7 carbon atoms, --CN, carbamoyl, amino, --OH, --SH, alkylthio and alkoxy of 1 to 4 carbon atoms, oxo, carboxyl and salified or esterified carboxyl, R.sub.1A is selected from the group consisting of ##STR356## R.sub.A and R.sub.B are individually selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms, Z.sub.A is selected from the group consisting of a simple bond, --O--, --S-- and oxidized sulfur, R.sub.3A is quaternary ammonium optionally substituted with at least one member of the group consisting of a) alkyl of 1 to 4 carbon atoms unsubstituted or substituted with at least one member of the group consisting of carbocyclic aryl and carbocyclic aryloxy where the carbocyclic aryl is phenyl, diphenyl or naphthyl, alkyl, alkoxy, carbonyl, halogen, --OH, protected, --OH, carboxy, salified or esterified carboxy, --NH.sub.2, acetamido monoalkylamino and dialkylamino, b) alkenyl and alkynyl of 2 to 4 carbon atoms, c) carbocyclic aryl, d) halogen, e) --NH.sub.2, f) --NO.sub.2, g) alkoxy and alkylthio of 1 to 4 carbon atoms, h) --OH or --SH, i) free salified or esterified carboxy, j) carbamoyl and k) cyclopentyl or cyclohexyl, R.sub.4 is selected from the group consisting of hydrogen and methoxy, a is selected from the group consisting of hydrogen, alkali, metal, alkaline earth metal, magnesium, --NH.sub.2, an organic amine selected form the group consisting of methylamine, propylamine, trimethylamine, diethylamine, triethylamine, N, N-dimethylthanolamine, tris(hydroxymethyl)amino methane, ethanolamine, pyridine, picoline, dicyclohexylamine, morpholine, benzylamine, procaine, lysine, arginine, histidine, and N-methylglucamine and esterified carboxy or --COOA is --COO.sup.-, n.sub.2 is an integer from 0 to 2 or a non-toxic, pharmaceutically acceptable acid addition salt.
- 2. A compound of claim 1 having the formula ##STR357## syn isomer wherein R' is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl and alkynyl of 2 to 6 carbon atoms and cycloalkyl of 3 to 6 carbon atoms, all unsubstituted or substituted as in claim 1, phenyl, diphenyl, naphthyl, thienyl, furyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, triazolyl, thiadiazolyl, oxadiazolyl, tetrazolyl, pyridinyl, pyurimidinyl, pyrazinyl, pyridazinyl, thiazinyl, oxazinyl, triazinyl, thiadiazinyl, oxadiazinyl, tetrazinyl, imidazolinyl, benzimidazolyl, benzothiazolyl, benzoxazole, R.sub.3A is selected from the group consisting of, pyridinium, quinolinium, isoquinolinium, cyclopentylpyridinium, and trimethylammonium and Z.sub.A has the definition of claim 1.
- 3. A compound of claim 2 wherein R' is selected from the group consisting of hydrogen, allyl, allyl substituted with chlorine of bromine, cyclobutyl and cyclopropyl unsubstituted or substituted with carboxy, phenyl, difluoromethyl, trifluoromethyl and methyl and isopropyl unsubstituted or substituted with carboxy, carbamoyl, nitrile, CH.sub.3 S-- or CH.sub.3 O--.
- 4. A compound of claim 2 wherein Z.sub.A is a simple bond and R'.sub.3A is an unsubstituted or substituted pyridinium.
- 5. A compound of claim 1 selected from the group consisting of the internal salt of (6S, 7S) 7-[3-[7-[[(2-amino-4-thiazolyl)-2-[Z-(difluoromethoxyimino-acetamido]-2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl)-2-(E)-propenyl]thieno-[2,3-b]-pyridinium; the internal salt of the (6S, 7S) 5-[3-[7-[[(2-amino-4-thiazolyl)-(methoxyiminoacetamidoe]-2-carboxy-8-oxo-4-thia-1-azabicyclo-[4,2,0]-oct-2-en-3-yl]-2(E)-propenyl]-2-methyl-thiazolo[4,5-c]-pyridinium; the internal salt of (6S, 7S) 7-[3-[7-[[(2-amino-4-thiazolyl)-2-(Z)-(methoxyiminoacetamido]-2-carboxy-8-oxo-4-thia-1-azabicyclo-[4,2,0]-oct-2-en-3-yl]-propen-2-(E)-yl]thieno[2,3-b]pyridinium; the internal salt of the Z isomer of (6S, 7S) 5-[3-[7-[[(2-amino-4-thiazolyl (difluoromethoxy)iminoacetamido]2-carboxy 8-oxo 4-thia 1-azabicyclo[4,2,0]-oct-2-en-3-yl]-2-(E)-propenyl]-2-methyl-thiazolo[4,5-c] pyridinium, 6S,7S,.DELTA.Z 5-[3-[7-[(2-amino thiazol 4-yl)-(methoxyimino) acetamido] 2-carboxy-8-oxo-4-thia-1-azabyciclo[4,2,0]oct-2-en-3-yl]-2(E)propenyl]-thiazolo[4,5c]pyridinium and 6S,7S syn isomer of 5-[3-[7-[(2-aminothiazol-4-yl) (difluoromethoxyimino) acetamido]2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0] oct-2-en-3-yl]-2 (E)propenyl]-thiazolo[4,5,c]pyridinium and 6S,7S syn isomer of 7-[3-[7-(2-aminothiazol-4-yl)(fluoromethoxuyimino) acetamido]2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl]2-(E)propenyl]thieno[2,3-b]pyridinium.
- 6. An antibacterial composition comprising an antibacterially effective amount of a compound of claim 1 and an inert pharmaceutical carrier.
- 7. A composition of claim 6 wherein R' is selected from the group consisting of hydrogen, allyl optionally substituted with chlorine or bromine, cyclobutyl and cyclopropyl optionally substituted with carboxy, phenyl, difluoromethyl, trifluoromethyl and methyl and isopropyl optionally substituted with carboxy, carbamoyl, nitrile CH.sub.3 S-- or CH.sub.3 O--.
- 8. A composition of claim 6 wherein Z.sub.A is a simple bond and R'.sub.3A is an unsubstituted or substituted pyridinium.
- 9. A composition of claim 6 wherein the compound is selected from the group consisting of the internal salt of (6S,7S) 7-[3-[7-[[2-amino-4-thiazolyl)-2-[Z-(difluoromethoxyiminoacetamido]-2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl 2-(E)-propenyl]thieno[2,3-b]pyridinium; the internal salt of the syn isomer of (6S,7S) 5-[3-[7-[[(2-amino-4-thiazolyl) (methoxyiminoacetamido]-2-carboxy-8-oxo-4-thia-1-azabicyclo-[4,2,0]-oct-2-en-3-yl]-2(E)-propenyl]-2-methyl thiazolo-[4,5-c]-pyridinium; the internal salt of (6S,7S) 7-[3-[7-[[(2-amino-4-thiazolyl)-2-(Z)-(methoxyiminoacetamido]-2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl]propen-2-(E)-yl]-thieno-[2,3-b]pyridinium; the internal salt of the Z isomer of (6S,7S) 5-[3-[7-[ [(2-amino-4-thiazolyl (difluoromethoxy)iminoacetamido]2-carboxy 8-oxo 4-thia 1-azabicyclo[4,2,0]-oct-2-en-3-yl]-2-(E)-propenyl]-2-methyl-thiazolo[4,5-c]pyridinium, 6S,7S,.DELTA.Z 5-[3-[7-[(2-amino thiazol 4-yl)-(methoxyimino) acetamido]2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl]-2(E)propenyl]thiazolo[4,5-c]pyridinium, 6S,7S syn isomer of 5-[3-[7-[(2-aminothiazol-4-yl) (difluoromethoxyimino) acetamido]2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl]-2(E)propenyl]-thiazolo[4,5,c]pyridinium and 6S,7S syn isomer of 7-[3-[7-(2-aminothiazol-4-yl)(fluoromethoxyimino)acetamido]2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl]2-(E)propenyl]thieno[2,3-b]pyridinium.
- 10. A method of treating or preventing bacterial infections in warm-blooded animals comprising administering to warm-blooded animals an antibacterioidally effective amount of a compound of claim 1.
- 11. A method of claim 10 wherein R' is selected from the group consisting of hydrogen, allyl unsubstituted or substituted with chlorine or bromine, cyclobutyl and cyclopropyl unsubstituted or substituted with carboxy, phenyl, difluoromethyl, trifluoromethyl and methyl and isopropyl unsubstituted or substituted with carboxy, carbamoyl, nitrile, CH.sub.3 S-- or CH.sub.3 O--.
- 12. A method of claim 10 wherein Z.sub.A is a simple bond and R'.sub.3A is an unsubstituted or substituted pyridinium.
- 13. A method of claim 10 wherein the compound is selected from the group consisting of the internal salt (6S,7S) of 7-[3-[7-[[2-amino-4-thiazolyl)-2-[Z-(difluoromethoxyimino-acetamido]-2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl-2-(E)-propenyl]thieno[2,3-b]pyridinium; the internal salt of the syn isomer of (6S,7S) 5-[3-[7-[[(2-amino-4-thiazolyl)-(methoxyiminoacetamido]-2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl]-2-(E)-propenyl]-2-methyl-thiazolo[4,5-c]pyridinium; the internal salt of (6S,7S) 7-[3-[7-[[(2-amino-4-thiazolyl)-2-(Z)-(methoxyiminoacetamido]-2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl]-propen-2-(E)-yl]-thieno-[2,3-b]pyridinium; the internal salt of the Z isomer of (6S,7S) 5-[3-[7-[[(2-amino-4-thiazolyl) (difluoromethoxy) iminoacetamido]2-carboxy 8-oxo 4-thia 1-azabicyclo-[4,2,0]-oct-2-en-3-yl]-2-(E)-propenyl]-2-methyl-thiazolo[4,5-c]pyridinium, 6S,7S,.DELTA.Z 5-[3-[7-[(2-amino thiazol 4-yl)-(methoxyimino) acetamido]2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl]-2(E)propenyl]thiazolo[4,5-c]pyridinium, 6S,7S syn isomer of 5-[3-[7-[(2-aminothiazol-4-yl) (difluoromethoxyimino) acetamido]2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl]-2(E)propenyl]-thiazolo[4,5,c]pyridinium and 6S,7S syn isomer of 7-[3-[7-(2-aminothiazol-4-yl)(fluoromethoxyimino)acetamido]2-carboxy-8-oxo-4-thia-1-azabicyclo[4,2,0]oct-2-en-3-yl]2-(E)propenyl]thieno[2,3-b]pyridinium.
- 14. A composition of claim 6 wherein the active compound has the formula ##STR358## syn isomer, wherein R' is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl and alkynyl of 2 to 6 carbon atoms all unsubstituted or substituted as in claim 1, phenyl, diphenyl, naphthyl, thienyl, furyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, triazolyl, thiadiazolyl, oxadiazolyl, tetrazolyl, pyridinyl pyimidinyl, pyrimidinyl, pyrazinyl, pyridazinyl, thiazinyl, oxazinyl, triazinyl, thiadiazinyl, oxadiazinyl, tetrazinyl, imidazolinyl, benzimidazolyl, benzothiazolyl, benzoxazole, R.sub.3A is selected from the group consisting of pyridinium, quinolinium, isoquinolinium cyclopentylpyridinium, and trimethylammonium and Z.sub.A has the definition of claim 1.
- 15. A method of claim 10 wherein the active compound has the formula ##STR359## syn isomer, wherein R' is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl and alkynyl of 2 to 6 carbon atoms and cycloalkyl of 3 to 6 carbon atoms and cycloalkyl of 3 to 6 carbon atoms, all unsubstituted or substituted as in claim 2, phenyl, diphenyl, naphthyl, thienyl, furyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, triazolyl, thiadiazolyl, oxadiazolyl, tetrazolyl, pyridinyl, pyrazinyl, pyridazinyl, thiazinyl, oxazinyl, triazinyl, thiadiazinyl, oxadiazinyl, tetrazinyl, imidazolinyl, benzimidazolyl, benzothiazolyl, benzoxazole, R.sub.3A is selected from the group consisting of pyridinium, quinolinium, isoquinolium, cyclopentyl pyridinium, trimethylammonium and Z.sub.A has the definition of claim 1.
Priority Claims (2)
Number |
Date |
Country |
Kind |
85 12218 |
Aug 1985 |
FRX |
|
87 01456 |
Feb 1987 |
FRX |
|
Parent Case Info
This application is a continuation of U.S. patent application Ser. No. 605,982 filed Oct. 30, 1990, now abandoned; which is a continuation of U.S. patent application Ser. No. 07/151,688 filed Feb. 2, 1988, now abandoned; which is a continuation-in-part of Ser. No. 895,175, filed Aug. 11, 1986, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4476124 |
Heymes et al. |
Oct 1984 |
|
4908359 |
Costerousse et al. |
Mar 1990 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
605982 |
Oct 1990 |
|
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
151688 |
Feb 1988 |
|
Parent |
895175 |
Aug 1986 |
|